7th Annual USC Multi-Disciplinary Breast Cancer Symposium


 

Treatment of 52 y/o Women With Inflammatory Breast Cancer - What Is the Best Treatment Option for Invasive Ductal Carcinomas? What Is Prognosis After Neoadjuvant Treatment?

91 views
February 28, 2020
Comments 0
Login to view comments. Click here to Login